New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Bhubaneswar police have banned DJ music during Dussehra idol immersion processions in the city,…
Bhubaneswar: Several trains to and from Puri will be temporarily short-terminated or short-originated from October…
Dhenkanal: The martial heritage of Odisha’s Paikas came alive at Kandabindha village in Dhenkanal district…
Bhubaneswar: Braj Mohan Ram on Sunday took oath as the new Governor of Odisha at…
Bhubaneswar: Recognising their gold medal-winning performances at the 2026 Asian Games in Japan, Odisha Chief…
Bhubaneswar: Two school-going sisters from Odisha have used a multiplication table to deliver a social…
